These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 17617291

  • 21. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]

  • 22. Dynamic splinting after treatment with botulinum toxin type-A: a randomized controlled pilot study.
    Lai JM, Francisco GE, Willis FB.
    Adv Ther; 2009 Feb; 26(2):241-8. PubMed ID: 19194671
    [Abstract] [Full Text] [Related]

  • 23. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW, Tan HJ, Norlinah MI, Nafisah WY, Ramesh S, Hamidon BB, Raymond AA.
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [Abstract] [Full Text] [Related]

  • 24. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M, Borriello G, Castri P, Prosperini L, Pozzilli C.
    Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
    [Abstract] [Full Text] [Related]

  • 25. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [Abstract] [Full Text] [Related]

  • 26. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
    Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P.
    J Neuroimaging; 2010 Jan; 20(1):9-15. PubMed ID: 19453837
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 28. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Jul; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 29. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M, Wissel J.
    Wien Klin Wochenschr; 2001 Jul; 113 Suppl 4():16-9. PubMed ID: 15506047
    [Abstract] [Full Text] [Related]

  • 30. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.
    Cousins E, Ward AB, Roffe C, Rimington LD, Pandyan AD.
    Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901
    [Abstract] [Full Text] [Related]

  • 31. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):395-400. PubMed ID: 12167681
    [Abstract] [Full Text] [Related]

  • 32. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu, Tiebin Yan, Jianning Mai.
    Clin Rehabil; 2009 Sep 08; 23(9):800-11. PubMed ID: 19482892
    [Abstract] [Full Text] [Related]

  • 33. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C, Jankovic J, Duane D.
    Mov Disord; 1998 Jan 08; 13(1):150-4. PubMed ID: 9452341
    [Abstract] [Full Text] [Related]

  • 34. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH, Whyte J, Wannstedt G, Ellis CA.
    Arch Phys Med Rehabil; 2008 May 08; 89(5):982-7. PubMed ID: 18452749
    [Abstract] [Full Text] [Related]

  • 35. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC, Chuang YC, Liu JP, Chien KL, Chen YM, Chen YF.
    Clin Rehabil; 2009 Jan 08; 23(1):64-71. PubMed ID: 19114438
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.
    Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL.
    Eur Urol; 2007 Sep 08; 52(3):850-8. PubMed ID: 17467889
    [Abstract] [Full Text] [Related]

  • 37. Undesirable distant effects following botulinum toxin type a injection.
    Roche N, Schnitzler A, Genêt F F, Durand MC, Bensmail D.
    Clin Neuropharmacol; 2008 Sep 08; 31(5):272-80. PubMed ID: 18836345
    [Abstract] [Full Text] [Related]

  • 38. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
    Moore AP, Ade-Hall RA, Smith CT, Rosenbloom L, Walsh HP, Mohamed K, Williamson PR.
    Neurology; 2008 Jul 08; 71(2):122-8. PubMed ID: 18606966
    [Abstract] [Full Text] [Related]

  • 39. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM, Schim JD, Chippendale TJ.
    Headache; 2008 Feb 08; 48(2):210-20. PubMed ID: 18047502
    [Abstract] [Full Text] [Related]

  • 40. Botulinum toxin for spasticity after stroke.
    Landau WM.
    N Engl J Med; 2003 Jan 16; 348(3):258-9; author reply 258-9. PubMed ID: 12529471
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.